This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Are You Looking for a High-Growth Dividend Stock? Clorox (CLX) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Clorox (CLX) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $208.53 in the latest trading session, marking a +0.18% move from the prior day.
The Zacks Analyst Blog Highlights: Novartis, Zoom Video, Caterpillar, Microsoft, Cisco, Clorox and LHC Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Novartis, Zoom Video, Caterpillar, Microsoft, Cisco, Clorox and LHC Group
Top Stock Reports for Novartis, Zoom Video & Caterpillar
by Sheraz Mian
Today's Research Daily features new research reports on 12 major stocks, including Novartis (NVS), Zoom Video Communications (ZM) and Caterpillar (CAT).
Church & Dwight (CHD) Gains on High Demand & Online Strength
by Zacks Equity Research
Church & Dwight (CHD) has been gaining from rising demand for essential items amid the pandemic. The company's online business is likely to perform well, thanks to social distancing trends.
Clorox (CLX) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Clorox (CLX) closed at $217.46, marking a +1.62% move from the previous day.
Why Clorox (CLX) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Clorox (CLX) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed at $212.52 in the latest trading session, marking a -1.94% move from the prior day.
Clorox (CLX) Down 7.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
This is Why Clorox (CLX) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Clorox (CLX): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Clorox (CLX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Church & Dwight Gains 30% in 3 Months on Pandemic-Led Demand
by Zacks Equity Research
Church & Dwight (CHD) gains on robust demand for household and personal care products amid the pandemic. High costs are a worry.
Why Clorox (CLX) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Clorox (CLX) have what it takes? Let's find out.
Wall Street Northbound Despite Several Concerns
by Zacks Equity Research
Wall Street Northbound Despite Several Concerns.
Clorox (CLX) Beats Q4 Earnings & Sales Estimates, Stock Down
by Zacks Equity Research
Clorox's (CLX) fourth-quarter fiscal 2020 results reflect gains from the robust demand for disinfecting and cleaning products due to the coronavirus outbreak, and broad-based growth at all segments.
Markets Start Week in Green Despite Plenty of Tumult
by Mark Vickery
With name-brand retailers declaring bankruptcy and Congress still at odds over a relief package, investors nevertheless bid up markets to start the week.
Clorox (CLX) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 20.50% and 6.75%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Newell Brands (NWL) Beats Q2 Earnings & Sales Estimates
by Zacks Equity Research
Strength in the Food and Commercial unit and higher demand for certain categories benefit Newell Brands' (NWL) Q2 results. However, it withdraws the 2020 view on COVID-19 impacts.
Is The Clorox (CLX) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Is (CLX) Outperforming Other Consumer Staples Stocks This Year?
Church & Dwight (CHD) Q2 Earnings & Sales Beat Estimates
by Zacks Equity Research
Church & Dwight's (CHD) impressive Q2 results gain from a rise in the demand for essentials in the wake of the COVID-19 crisis. Also, management raises the 2020 view.
Colgate (CL) Q2 Earnings & Sales Beat Estimates, Stock Up
by Zacks Equity Research
Colgate's (CL) second-quarter 2020 results reflect strength in North America and Hill's segments as well as robust volume growth and pricing across regions.
Procter & Gamble (PG) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Procter & Gamble's (PG) Q4 results benefited from rising demand for its products, which have been deemed essential items.
Archer Daniels' (ADM) Stock Up on Q2 Earnings & Sales Beat
by Zacks Equity Research
Archer Daniels' (ADM) better-than-expected Q2 results gain from strength in the Nutrition segment.
Here Are the Factors Influencing Clorox's (CLX) Q4 Earnings
by Zacks Equity Research
Clorox's (CLX) Q4 performance is likely to have gained on increased demand for its products due to the coronavirus outbreak and cost-saving plans. However, currency woes and high costs are concerning.
Clorox (CLX) Stock Moves -0.29%: What You Should Know
by Zacks Equity Research
Clorox (CLX) closed the most recent trading day at $228.55, moving -0.29% from the previous trading session.